Reuters logo
BRIEF-Chemocentryx reports presentation of positive data from ongoing pilot phase II trial of CCX168
October 17, 2016 / 12:47 PM / a year ago

BRIEF-Chemocentryx reports presentation of positive data from ongoing pilot phase II trial of CCX168

Oct 17 (Reuters) - Chemocentryx Inc :

* Chemocentryx announces presentation of positive data from ongoing pilot phase II trial of CCX168 (avacopan) in atypical hemolytic uremic syndrome (AHUS) at ASN kidney week 2016

* Chemocentryx Inc - initiating a multi-center clinical trial in patients with ahus in 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below